A manufacturer designates an authorized representative, an entity located in a Member State, to fulfill regulatory obligations on their behalf.
An authorized representative based in Poland notifies the President of the Office at least 14 days before introducing a device to the market or initiating the evaluation process.
Manufacturers without a presence in a Member State appoint an authorized representative responsible for ensuring product conformity assessment and market placement.
Search Article
Ready to Get Started?
Ensuring your medical products meet standards, navigate regulations, and gain market access smoothly